The Picornaviridae virus family contains a large number of human pathogens such as poliovirus, hepatitis A virus and rhinoviruses. Amongst the viruses belonging to the genus Enterovirus, several serotypes of coxsackievirus coexist for which neither vaccine nor therapy is available. Coxsackievirus B3 is involved in the development of acute myocarditis and dilated cardiomyopathy and is thought to be an important cause of sudden death in young adults. Here, the first crystal of a coxsackievirus RNA-dependent RNA polymerase is reported. Standard crystallization methods yielded crystals that were poorly suited to X-ray diffraction studies, with one axis being completely disordered. Crystallization was improved by testing crystallization solutions from commercial screens as additives. This approach yielded crystals that diffracted to 2.1 A resolution and that were suitable for structure determination.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2335076 | PMC |
| http://dx.doi.org/10.1107/S1744309107020416 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Coxsackievirus B3-Induced mA Modification of RNA Enhances Viral Replication via Suppression of YTHDF-Mediated Stress Granule Formation.
Microorganisms
October 2024
Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.
N6-methyladenosine (mA) is the most prevalent internal RNA modification. Here, we demonstrate that coxsackievirus B3 (CVB3), a common causative agent of viral myocarditis, induces mA modification primarily at the stop codon and 3' untranslated regions of its genome. As a positive-sense single-stranded RNA virus, CVB3 replicates exclusively in the cytoplasm through a cap-independent translation initiation mechanism.
View Article and Find Full Text PDFSynthesis, characterization, molecular docking, pharmacokinetics, and molecular dynamics of new bis-thiazoles based on bis-thiosemicarbazone as anti-coxsackievirus.
Sci Rep
November 2024
Applied Organic Chemistry Department, National Research Centre, Dokki, 12622, Cairo, Egypt.
Article Synopsis
- * The article explores the synthesis of bis-thiazole derivatives as potential antiviral candidates against Coxsackievirus B, focusing on one particularly effective derivative, 7a, which inhibits both viral adsorption and replication.
- * Molecular docking studies revealed that several compounds effectively bind to significant Cox B virus proteins, suggesting their ability to inhibit viral enzyme activity, while an ADMET study indicates these compounds meet favorable physicochemical criteria for drug development.
Novel Intertypic Recombinant Coxsackievirus A2 Containing Specific Amino Acid Mutations in the RNA-Dependent RNA Polymerase Potentially Associated With Its Emergence.
J Med Virol
November 2024
Department of Microbiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Coxsackievirus A2 (CVA2), a member of enterovirus A species (EV-A), is associated with diverse human diseases and occasionally causes acute gastroenteritis (AGE). In Thailand, CVA2 emerged as the predominant genotype in 2019. The increasing incidence of CVA2, coupled with the limited availability of full-length genomes, highlights the need for more complete genome sequence analysis to facilitate molecular epidemiology study.
View Article and Find Full Text PDFDistinct chikungunya virus polymerase palm subdomains contribute to viral protein accumulation and virion production.
PLoS Pathog
October 2024
Department of Microbiology, New York University Grossman School of Medicine, New York, New York, United States of America.
Article Synopsis
- Alphaviruses, like chikungunya virus, rely on an error-prone RNA-dependent RNA polymerase (nsP4) for genome replication, but the full role of nsP4 in the virus life cycle is unclear.
- Researchers studied the significance of a key residue (C483) in nsP4 and created various nsP4 variants to explore their effects on viral replication in mammalian and mosquito cells.
- Their findings reveal that specific subdomains of nsP4 are critical for both RNA transcription and virion production, with temperature conditions impacting virus infectivity but enhancing replication and protein production in mammalian cells.
TRIM56 restricts Coxsackievirus B infection by mediating the ubiquitination of viral RNA-dependent RNA polymerase 3D.
PLoS Pathog
September 2024
Department of Cell Biology, Harbin Medical University, Harbin, China.
Article Synopsis
- Coxsackievirus B (CVB) is linked to serious illnesses like myocarditis, meningitis, and pancreatitis, with no effective antiviral treatments available due to incomplete understanding of its pathogenesis.
- The study identifies that the 3D protein of CVB3 undergoes K48-linked polyubiquitination, leading to its degradation by the proteasome, with E3 ligase TRIM56 playing a crucial role in this process.
- Findings suggest that TRIM56 acts as a cellular defense mechanism against CVB infection, indicating that boosting viral protein degradation may provide a new strategy for managing CVB infections.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!